{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:28:53Z","timestamp":1769581733109,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670136"],"award-info":[{"award-number":["81670136"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA21765"],"award-info":[{"award-number":["CA21765"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007737","name":"Saint Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.lanwpc.2023.100818","type":"journal-article","created":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T15:18:19Z","timestamp":1686410299000},"page":"100818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: a case\u2013control study"],"prefix":"10.1016","volume":"38","author":[{"given":"Jiaoyang","family":"Cai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaowen","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuli","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuedong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changda","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-kong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun J.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-5658","authenticated-orcid":false,"given":"Ching-Hon","family":"Pui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2023.100818_bib1","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"16","key":"10.1016\/j.lanwpc.2023.100818_bib2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.lanwpc.2023.100818_bib3","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1200\/JCO.2015.64.6364","article-title":"Successful therapy reduction and intensification for childhood acute lymphoblastic leukemia based on minimal residual disease monitoring: study ALL10 from the Dutch childhood oncology group","volume":"34","author":"Pieters","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.lanwpc.2023.100818_bib4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1182\/bloodadvances.2018016584","article-title":"Refining risk classification in childhood B acute lymphoblastic leukemia: results of DFCI ALL Consortium Protocol 05-001","volume":"2","author":"Vrooman","year":"2018","journal-title":"Blood Adv"},{"issue":"15","key":"10.1016\/j.lanwpc.2023.100818_bib5","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1200\/JCO.2003.03.068","article-title":"Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment","volume":"21","author":"Dalton","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.lanwpc.2023.100818_bib6","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpeds.2012.12.037","article-title":"Longitudinal linear growth and final height is impaired in childhood acute lymphoblastic leukemia survivors after treatment without cranial irradiation","volume":"163","author":"Vandecruys","year":"2013","journal-title":"J\u00a0Pediatr"},{"issue":"21","key":"10.1016\/j.lanwpc.2023.100818_bib7","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1002\/cncr.31736","article-title":"Changes in body mass\u00a0index, height, and weight in children during and after\u00a0therapy for acute lymphoblastic leukemia","volume":"124","author":"Browne","year":"2018","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpeds.2011.03.046","article-title":"Distinct impact of imatinib on growth at prepubertal and pubertal ages of children with chronic myeloid leukemia","volume":"159","author":"Shima","year":"2011","journal-title":"J\u00a0Pediatr"},{"issue":"5","key":"10.1016\/j.lanwpc.2023.100818_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/pbc.24121","article-title":"Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia","volume":"59","author":"Rastogi","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1016\/j.lanwpc.2023.100818_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.23389","article-title":"Imatinib has adverse effect on growth in children with chronic myeloid leukemia","volume":"59","author":"Bansal","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"18","key":"10.1016\/j.lanwpc.2023.100818_bib11","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1016\/j.ejca.2014.10.007","article-title":"Growth deceleration in children treated with imatinib for chronic myeloid leukaemia","volume":"50","author":"Millot","year":"2014","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/bjh.15633","article-title":"Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia","volume":"185","author":"Sabnis","year":"2019","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/08880018.2019.1610119","article-title":"Effect of imatinib on growth in children with chronic myeloid leukemia","volume":"36","author":"Boddu","year":"2019","journal-title":"Pediatr Hematol Oncol"},{"issue":"3","key":"10.1016\/j.lanwpc.2023.100818_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12185-020-03042-1","article-title":"Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China","volume":"113","author":"Cai","year":"2021","journal-title":"Int J Hematol"},{"issue":"S1","key":"10.1016\/j.lanwpc.2023.100818_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.HS9.0000559876.36369.09","volume":"3","author":"Patterson","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.lanwpc.2023.100818_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2020.106405","article-title":"Impact of tyrosine kinase inhibitors on the statural growth in children with acute lymphoblastic leukemia","volume":"95","author":"Zheng","year":"2020","journal-title":"Leuk Res"},{"issue":"3","key":"10.1016\/j.lanwpc.2023.100818_bib17","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jamaoncol.2019.5868","article-title":"Effect of dasatinib vs imatinib in the treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: a randomized clinical trial","volume":"6","author":"Shen","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.2020010438","article-title":"Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation","volume":"138","author":"Tang","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.lanwpc.2023.100818_bib19","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S1470-2045(21)00328-4","article-title":"Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial","volume":"22","author":"Yang","year":"2021","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.lanwpc.2023.100818_bib20","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","article-title":"Treating childhood acute lymphoblastic leukemia without cranial irradiation","volume":"360","author":"Pui","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"35","key":"10.1016\/j.lanwpc.2023.100818_bib21","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1200\/JCO.19.01692","article-title":"Improved CNS control of childhood acute lymphoblastic leukemia without cranial irradiation: St Jude total therapy study 16","volume":"37","author":"Jeha","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/pbc.22127","article-title":"Cost of childhood acute lymphoblastic leukemia care in Shanghai, China","volume":"53","author":"Liu","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hon.2541","article-title":"Long-term results of the risk-stratified treatment of childhood acute lymphoblastic leukemia in China","volume":"36","author":"Shen","year":"2018","journal-title":"Hematol Oncol"},{"issue":"4","key":"10.1016\/j.lanwpc.2023.100818_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clml.2018.02.010","article-title":"Efficacy of ponatinib versus earlier generation tyrosine kinase inhibitors for front-line treatment of newly diagnosed Philadelphia-positive acute lymphoblastic leukemia","volume":"18","author":"Jabbour","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"17","key":"10.1016\/j.lanwpc.2023.100818_bib25","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa2016272","article-title":"GIMEMA investigators. Dasatinib-blinatumomab for ph-positive acute lymphoblastic leukemia in adults","volume":"383","author":"Fo\u00e0","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.lanwpc.2023.100818_bib26","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1200\/JCO.2017.76.7228","article-title":"Dasatinib plus intensive chemotherapy in children, adolescents, and young adults with Philadelphia chromosome-positive acute lymphoblastic leukemia: results of Children's oncology group trial AALL0622","volume":"36","author":"Slayton","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"Supplement 1","key":"10.1016\/j.lanwpc.2023.100818_bib27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood.V130.Suppl_1.98.98","article-title":"CA180-372: an international collaborative phase 2 trial of dasatinib and chemotherapy in pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL)","volume":"130","author":"Hunger","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.lanwpc.2023.100818_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.clinthera.2021.05.009","article-title":"A\u00a0higher dose of dasatinib may increase the possibility of crossing the blood-brain barrier in the treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"43","author":"Gong","year":"2021","journal-title":"Clin Ther"},{"issue":"19","key":"10.1016\/j.lanwpc.2023.100818_bib29","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa051140","article-title":"Altered bone and mineral metabolism in patients receiving imatinib mesylate","volume":"354","author":"Berman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.lanwpc.2023.100818_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3324\/haematol.12373","article-title":"Increased cortical bone mineralization in imatinib treated patients with chronic myelogenous leukemia","volume":"93","author":"J\u00f6nsson","year":"2008","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.lanwpc.2023.100818_bib31","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/pbc.24397","article-title":"Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH\/IGF-1 axis","volume":"60","author":"Narayanan","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.lanwpc.2023.100818_bib32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/pbc.26028","article-title":"Recognizing endocrinopathies associated with tyrosine kinase inhibitor therapy in children with chronic myelogenous leukemia","volume":"63","author":"Samis","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"22","key":"10.1016\/j.lanwpc.2023.100818_bib33","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1182\/blood.2018882233","article-title":"How I treat chronic myeloid leukemia in children and adolescents","volume":"133","author":"Hijiya","year":"2019","journal-title":"Blood"},{"issue":"9373","key":"10.1016\/j.lanwpc.2023.100818_bib34","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1016\/S0140-6736(03)13554-4","article-title":"Gynaecomastia in men with chronic myeloid leukaemia after imatinib","volume":"361","author":"Gambacorti-Passerini","year":"2003","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.lanwpc.2023.100818_bib35","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1182\/blood-2010-07-294330","article-title":"Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib","volume":"117","author":"Haouala","year":"2011","journal-title":"Blood"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606523001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606523001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:41:25Z","timestamp":1763001685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606523001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":35,"alternative-id":["S2666606523001360"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100818","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the tyrosine kinase inhibitors on the growth in children with Philadelphia chromosome\u2013positive acute lymphoblastic leukemia: a case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100818","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100818"}}